Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(01)00014-7PMID 11282195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States

  2000cited by this paper
• Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs.

  2000cited by this paper
• Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen1

  2000cited by this paper
• A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice.

  2000cited by this paper
• Evolution of Swine H3N2 Influenza Viruses in the United States

  2000cited by this paper
• DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza.

  2000cited by this paper
• Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes.

  2000cited by this paper
• Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

  1999cited by this paper
• Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.

  1999cited by this paper
• Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.

  1999cited by this paper
• Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.

  1999cited by this paper
• DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice

  1999cited by this paper
• IL-6 induces long-term protective immunity against a lethal challenge of influenza virus.

  1999cited by this paper
• Intradermal DNA immunization by using jet-injectors in mice and monkeys.

  1999cited by this paper
• A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation.

  1999cited by this paper
• Genetic Reassortment of Avian, Swine, and Human Influenza A Viruses in American Pigs

  1999cited by this paper
• Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice

  1999cited by this paper
• Fatal case of swine influenza virus in an immunocompetent host.

  1998cited by this paper
• Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.

  1998cited by this paper
• In vivo gene transfer to skin and wound by microseeding.

  1998cited by this paper
• Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine.

  1998cited by this paper
• Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes.

  1998cited by this paper
• Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus

  1998cited by this paper
• Classic swine influenza

  1998cited by this paper
• Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus

  1998cited by this paper
• Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model

  1998cited by this paper
• Superiority of the ear pinna over muscle tissue as site for DNA vaccination

  1998cited by this paper
• Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.

  1998cited by this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cited by this paper
• Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen.

  1998cited by this paper
• Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein.

  1998cited by this paper
• Studies of the Neutralizing Activity and Avidity of Anti-Human Immunodeficiency Virus Type 1 Env Antibody Elicited by DNA Priming and Protein Boosting

  1998cited by this paper
• Coadministration of DNA Encoding Interleukin-6 and Hemagglutinin Confers Protection from Influenza Virus Challenge in Mice

  1998cited by this paper
• Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium

  1997cited by this paper
• Mucosal immunization with DNA encoding influenza hemagglutinin.

  1997cited by this paper
• Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.

  1997cited by this paper
• DNA vaccines -- a modern gimmick or a boon to vaccinology?

  1997cited by this paper
• Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

  1997cited by this paper
• Summary and Speculation

  1997cited by this paper
• Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

  1997cited by this paper
• DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

  1997cited by this paper
• DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity.

  1997cited by this paper
• Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.

  1997cited by this paper
• Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.

  1997cited by this paper
• Transmission of swine influenza virus to humans after exposure to experimentally infected pigs.

  1997cited by this paper
• Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice

  1996cited by this paper
• DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

  1996cited by this paper
• Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization.

  1996cited by this paper
• DNA immunization against experimental genital herpes simplex virus infection.

  1996cited by this paper
• Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study

  1996cited by this paper
• Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs.

  1996cited by this paper
• Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

  1996cited by this paper
• Protection against papillomavirus with a polynucleotide vaccine.

  1996cited by this paper
• DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.

  1996cited by this paper
• Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.

  1996cited by this paper
• DNA immunization confers protection against murine cytomegalovirus infection

  1996cited by this paper
• Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza

  1996cited by this paper
• Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

  1995cited by this paper
• Immune responses to nucleic acid vaccines to rabies virus.

  1995cited by this paper
• Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin

  1995cited by this paper
• Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin.

  1994cited by this paper
• An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza

  1994cited by this paper
• Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

  1994cited by this paper
• Gene transfer into mammalian cells by particle bombardment.

  1994cited by this paper
• Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.

  1994cited by this paper
• Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

  1993cited by this paper
• DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

  1993cited by this paper
• Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene

  1993cited by this paper
• Pathogenicity of a swine influenza H1N1 virus antigenically distinguishable from classical and European strains

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.

  1992cited by this paper
• Evolution and ecology of influenza A viruses

  1992cited by this paper
• Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection.

  1991cited by this paper
• Immunoglobulin A mediation of murine nasal anti-influenza virus immunity

  1991cited by this paper
• Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

  1990cited by this paper
• Fatal swine influenza pneumonia during late pregnancy.

  1990cited by this paper
• Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.

  1990cited by this paper
• Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands.

  1988cited by this paper
• Fish farming and influenza pandemics

  1988cited by this paper
• Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine.

  1986cited by this paper
• Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

  1986cited by this paper
• The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses.

  1985cited by this paper
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

  1984cited by this paper
• Sporadic occurrence of zoonotic swine influenza virus infections

  1984cited by this paper
• Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child.

  1984cited by this paper
• Cytotoxic T-cell immunity to influenza.

  1983cited by this paper
• Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

  1983cited by this paper
• Investigation of the incidence of influenza A viraemia caused by virus strains circulating among children in 1968 - 1977.

  1979cited by this paper
• Investigation of the incidence of influenza A viraemia caused by virus strains circulating among children in 1968 - 1977.

  1979cited by this paper
• Determinants of immunity to influenza infection in man.

  1979cited by this paper
• The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine.

  1978cited by this paper
• Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation.

  1977cited by this paper
• Isolation of swine influenza virus from autopsy lung tissue of man.

  1976cited by this paper
• Protection with split and whole virus vaccines against influenza.

  1973cited by this paper
• VIRAEMIA IN INFLUENZA: A REPORT OF TWO CASES

  1971cited by this paper
• Proved viraemia in asian influenza (Hong Kong variant) during incubation period

  1969cited by this paper
• Viremia in Asian influenza.

  1966cited by this paper
• HUMAN INFLUENZA INFECTION WITH PROVED VIREMIA. REPORT OF A CASE.

  1963cited by this paper
• EXPERIENCES WITH ENCEPHALOGRAPHY

  1929cited by this paper

• Swine influenza A virus: challenges and novel vaccine strategies

  2024cites this paper
• Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies

  2020cites this paper
• A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.

  2019cites this paper
• EFSA Panel Animal Health and Welfare (AHAW); Scientific Opinion on the pandemic (H1N1) 2009 influenza and its potential implications for animal health. EFSA-Q-2009-00935

  2018cites this paper
• EFSA Panel Animal Health and Welfare (AHAW); Scientific Opinion on the pandemic (H1N1) 2009 influenza and its potential implications for animal health. EFSA-Q-2009-00935

  2018cites this paper
• Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses

  2018cites this paper
• Protective effect of a polyvalent influenza DNA vaccine in pigs

  2018cites this paper
• EFSA Panel Animal Health and Welfare (AHAW); Scientific Opinion on the pandemic (H1N1) 2009 influenza and its potential implications for animal health. EFSA-Q-2009-00935

  2018cites this paper
• Immune efficacy of an adenoviral vector‐based swine influenza vaccine against antigenically distinct H1N1 strains in mice

  2017cites this paper
• Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection

  2017cites this paper
• A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs

  2016cites this paper
• Vaccines and vaccination for swine influenza: differing situations in Europe and the USA

  2016cites this paper
• Vaccines against influenza A viruses in poultry and swine: Status and future developments.

  2015cites this paper
• Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test.

  2015cites this paper
• Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.

  2013cites this paper
• Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine

  2013cites this paper
• Swine influenza virus vaccines: to change or not to change-that's the question.

  2013cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Scientific opinion on the possible risks posed by the influenza A ( H 3 N 2 v ) virus for animal health and its potential spread and implications for animal and human health

  2013cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Vaccine development for protecting swine against influenza virus

  2012cites this paper
• Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

  2012cites this paper
• Studies on influenza virus replicon particle vaccines in pigs

  2012influential citation
• DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs

  2011cites this paper
• An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1.

  2011cites this paper
• Swine Influenza Viruses in Pigs 2

  2011cites this paper
• Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.

  2011cites this paper
• Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus

  2010cites this paper
• EFSA Panel Animal Health and Welfare (AHAW); Scientific Opinion on the pandemic (H1N1) 2009 influenza and its potential implications for animal health. EFSA-Q-2009-00935

  2010cites this paper
• Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.

  2010cites this paper
• Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres

  2010cites this paper
• EFSA Panel Animal Health and Welfare (AHAW); Scientific Opinion on the pandemic (H1N1) 2009 influenza and its potential implications for animal health. EFSA-Q-2009-00935

  2010cites this paper
• Prime-Boost Immunization Using a DNA Vaccine Delivered by Attenuated Salmonella enterica Serovar Typhimurium and a Killed Vaccine Completely Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus

  2010cites this paper
• Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.

  2009cites this paper
• Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ

  2009cites this paper
• Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.

  2009cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• Strategy to improve swine influenza virus (SIV) vaccination

  2007cites this paper
• Immunostimulatory properties of a novel adjuvant administered with inactivated influenza virus vaccine.

  2007cites this paper
• Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease.

  2007cites this paper
• Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.

  2006cites this paper
• Particulate delivery systems for animal vaccines.

  2006cites this paper
• DNA Vaccines for Mucosal Immunity to Infectious Diseases

  2005cites this paper
• DNA vaccines and their application against parasites--promise, limitations and potential solutions.

  2004cites this paper
• Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

  2004cites this paper
• Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs.

  2002cites this paper
• CLONAGEM E CARACTERIZAÇÃO PARCIAL DO cDNA DE UMA PROTEÍNA DE Boophilus microplus SIMILAR À CORONINA

  2002cites this paper
• Development of a Vaccine against Murine Cytomegalovirus (MCMV), Consisting of Plasmid DNA and Formalin-Inactivated MCMV, That Provides Long-Term, Complete Protection against Viral Replication

  2002cites this paper
• Non‐Lethal Viral Challenge of Influenza Haemagglutinin and Nucleoprotein DNA Vaccinated Mice Results in Reduced Viral Replication

  2002cites this paper
• Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States

  2000cites this paper